Glaucoma Genetics: Lessons Learned and the New Frontier.
Summary
Priorities for future work include the discovery of novel genes and genetic causality, as well as functional studies to define molecular mechanisms underlying disease pathophysiology.
Abstract
Genetic analyses have led to the identification of 12 genes primarily responsible for early-onset glaucoma and hundreds of genomic loci influencing adult-onset disease risk. Childhood glaucoma genes encode for proteins involved in ocular development and extracellular matrix, while genetic factors influencing adult-onset disease are involved in a number of biological pathways and processes. Genes responsible for glaucoma and genetic factors influencing disease risk can be used for genetic testing, allowing for informed genetic counseling for early-onset glaucoma cases and families and risk stratification using PRS for adult-onset disease. Genetic testing for glaucoma can identify people with high disease risk and allow for surveillance and timely treatment that can prevent permanent loss of vision. Current studies suggest that glaucoma genetic architecture is complex, especially in adult-onset disease, involving multiple genetic and/or environmental risk factors. Priorities for future work include the discovery of novel genes and genetic causality, as well as functional studies to define molecular mechanisms underlying disease pathophysiology. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Keywords
More by Janey L Wiggs
View full profile →Intraocular Pressure, Glaucoma, and Dietary Caffeine Consumption: A Gene-Diet Interaction Study from the UK Biobank.
Association of Long-term Ambient Black Carbon Exposure and Oxidative Stress Allelic Variants With Intraocular Pressure in Older Men.
Association of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE ε4.
Top Research in Epidemiology & Genetics
Browse all →The Risks and Benefits of Myopia Control.
Two Phase 3 Clinical Trials Comparing the Safety and Efficacy of Netarsudil to Timolol in Patients With Elevated Intraocular Pressure: Rho Kinase Elevated IOP Treatment Trial 1 and 2 (ROCKET-1 and ROCKET-2).
Neuroprotective strategies for retinal disease.
In the Knowledge Library
Discussion
Comments and discussion will appear here in a future update.